Capital International’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-63,416
| Closed | -$561K | – | 166 |
|
|
2023
Q1 | $561K | Hold |
63,416
| – | – | 0.03% | 155 |
|
|
2022
Q4 | $578K | Buy |
63,416
+16,587
| +35% | +$151K | 0.04% | 151 |
|
|
2022
Q3 | $378K | Buy |
+46,829
| New | +$378K | 0.03% | 155 |
|
|
2021
Q3 | – | Sell |
-38,769
| Closed | -$384K | – | 161 |
|
|
2021
Q2 | $384K | Sell |
38,769
-19,444
| -33% | -$193K | 0.02% | 156 |
|
|
2021
Q1 | $672K | Sell |
58,213
-62,641
| -52% | -$723K | 0.04% | 147 |
|
|
2020
Q4 | $1.17M | Buy |
120,854
+8,409
| +7% | +$81.1K | 0.07% | 142 |
|
|
2020
Q3 | $1.01M | Buy |
112,445
+19,213
| +21% | +$173K | 0.07% | 145 |
|
|
2020
Q2 | $1.15M | Buy |
93,232
+33,832
| +57% | +$417K | 0.11% | 128 |
|
|
2020
Q1 | $533K | Buy |
+59,400
| New | +$533K | 0.06% | 155 |
|